6-(4-hydroxyphenylhydrazino)uracil: antimicrobial agent which selectively blocks replication of DNA synthesis in Bacillus subtilis by inhibiting DNA polymerase III [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 135596598 |
| MeSH ID | M0057466 |
| Synonym |
|---|
| h2-hpura |
| 40855-14-9 |
| 6-(4-hydroxyphenylhydrazino)uracil |
| 6-(2-(4-hydroxyphenyl)hydrazino)-2,4(1h,3h)-pyrimidinedione |
| 6-(p-hydroxyphenylhydrazino)uracil |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||